Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA topoisomerase I is a critical nuclear enzyme responsible for maintaining proper levels of supercoiling in cellular genomes by introducing transient single-strand breaks into duplex DNA. Its action ensures smooth progression through fundamental genetic processes while also serving as an important drug target in oncology due to its role in genome stability maintenance.
Single-strand cleavage/ligation via transesterification; trapping covalent complexes between enzyme and cleaved DNA ("TopI poisons") leading to cytotoxic lesions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA Topoisomerase I (Top1).